BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3952515)

  • 1. Prednimustine: the rationale for clinical development.
    Schein PS; Cavalli F
    Semin Oncol; 1986 Mar; 13(1 Suppl 1):1-2. PubMed ID: 3952515
    [No Abstract]   [Full Text] [Related]  

  • 2. Prednimustine for prostate cancer therapy.
    Slack NH; Murphy GP
    Compr Ther; 1979 Sep; 5(9):54-7. PubMed ID: 487742
    [No Abstract]   [Full Text] [Related]  

  • 3. Prednimustine.
    Semin Oncol; 1986 Mar; 13(1 Suppl 1):1-44. PubMed ID: 3952516
    [No Abstract]   [Full Text] [Related]  

  • 4. The antitumor effect of prednimustine in vitro and in vivo.
    Hartley-Asp B
    Semin Oncol; 1986 Mar; 13(1 Suppl 1):3-7. PubMed ID: 3952519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase III study of prednimustine (LEO 1031) in advanced breast cancer. A preliminary report.
    Rørth M; Løber J; Dombernowsky P; Krusenstjerna-Hofstrom D; Mattsson W; Mouridsen HT
    Eur J Cancer (1965); 1980; Suppl 1():137-40. PubMed ID: 7032923
    [No Abstract]   [Full Text] [Related]  

  • 6. Prednimustine in advanced malignant melanoma: a phase II study.
    Pedersen L; Løber J; Dalmark M; Mouridsen HT
    Cancer Treat Rep; 1987 Dec; 71(12):1315-6. PubMed ID: 3690549
    [No Abstract]   [Full Text] [Related]  

  • 7. Prednimustine in elderly patients with multiple myeloma: a phase II study.
    Tirelli U; Sorio R; Magri MD; Zagonel V; Vaccher E; Carbone A; Trovò M; Grigoletto E
    Cancer Treat Rep; 1986 Apr; 70(4):537-8. PubMed ID: 3698051
    [No Abstract]   [Full Text] [Related]  

  • 8. Phase II trial of prednimustine in glioblastoma multiforme.
    Andersen J; Christensen L; Kongsholm H
    Cancer Treat Rep; 1984 May; 68(5):795-7. PubMed ID: 6327038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacokinetics of prednimustine and chlorambucil in the rat.
    Newell DR; Shepherd CR; Harrap KR
    Cancer Chemother Pharmacol; 1981; 6(1):85-91. PubMed ID: 7273268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II trial of prednimustine (NSC-134087) in the treatment of small-cell anaplastic carcinoma of the lung.
    Jensen HS; Hansen HH; Dombernowsky P
    Cancer Chemother Pharmacol; 1980; 4(4):259-61. PubMed ID: 6254684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase III trial comparing prednimustine (LEO 1031) to chlorambucil plus prednisolone in advanced breast cancer.
    Løber J; Mouridsen HT; Christiansen IE; Dombernowsky P; Mattsson W; Rørth M
    Cancer; 1983 Nov; 52(9):1570-6. PubMed ID: 6352005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prednimustine in adult acute myeloid leukaemia.
    Brandt L; Könyves I
    Cancer Chemother Pharmacol; 1979; 2(2):133-6. PubMed ID: 394873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II trial of Prednimustine. Leo-1031 (NSC-134087) in acute non-lymphocytic leukemia.
    Juul K; Sørensen P; Pedersen-Bjergaard J; Jensen MK
    Scand J Haematol; 1979 Nov; 23(5):388-92. PubMed ID: 396664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of chlorambucil in man after administration of the free drug and its prednisolone ester (prednimustine, Leo 1031).
    Ehrsson H; Wallin I; Nilsson SO; Johansson B
    Eur J Clin Pharmacol; 1983; 24(2):251-3. PubMed ID: 6840176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical trial of prednimustine, Leo-1031 (NSC-134087), in patients with non-Hodgkin lymphomata and chronic lymphocytic leukaemia previously treated with steroids and alkylating agents.
    Pedersen-Bjergaard J; Hansen MM; Geisler CH; Nissen NI
    Acta Med Scand; 1980; 207(3):215-20. PubMed ID: 6989170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical pharmacology of chlorambucil and prednimustine.
    Newell DR; Calvert AH; Harrap KR; McElwain TJ
    Br J Clin Pharmacol; 1983 Dec; 16(6):762-3. PubMed ID: 6661370
    [No Abstract]   [Full Text] [Related]  

  • 17. Phase II trial of prednimustine, L-1031, (NSC-134087) in advanced breast cancer.
    Mouridsen HT; Kristensen D; Nielsen JH; Dombernowsky P
    Cancer; 1980 Jul; 46(2):253-5. PubMed ID: 7388770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase II study of prednimustine in acute non-lymphocytic leukemia, smouldering leukemia, and refractory anemia with excess blasts.
    Gandara DR; Ries CA; Schiff SA; George CB; Lewis JP; Koretz MM; Carter SK
    Cancer Chemother Pharmacol; 1982; 9(1):10-2. PubMed ID: 7139848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A phase II study of prednimustine in advanced ovarian cancer].
    Grundsell H; Johnsson JE; Tropé C
    Lakartidningen; 1980 Sep; 77(39):3394-7. PubMed ID: 6161283
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on the pharmacokinetics of chlorambucil and prednimustine in man.
    Newell DR; Calvert AH; Harrap KR; McElwain TJ
    Br J Clin Pharmacol; 1983 Feb; 15(2):253-8. PubMed ID: 6849759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.